USSTOCK.TODAY
Regular Market
Log in Sign up

Regeneron Beats Q3 Revenue and Profit Estimates, Shares Rise 4%

Investing.com +1 · ·by G4L

REGN Regeneron Pharmaceuticals Inc
$916.06 -0.42%
View chart & analysis →
SNY +0.23%
  1. 1Regeneron recorded Q3 revenue of $5.12 billion.
  2. 2Regeneron recorded Q3 adjusted net income per share of $20.07.
  3. 3Regeneron shares rose 4% during Friday pre-market trading.

So what's the key point?

Regeneron earned more money in the third quarter than expected. Following this news, the stock price rose 4%.

Source Investing.com +1 · View original ↗

Related 3-line summaries

Nurix Therapeutics Inc. Shares Plunge on Sanofi Program Discontinuation Investing.com +2 · Nov 4Sanofi raises 2026 guidance as Q3 sales reach 14.4 billion euros The Motley Fool +1 · Nov 3AstraZeneca Cost Cutting, Alnylam Shares Plunge, Regeneron Earnings Beat BioPharma Dive · Nov 2
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news